STAT3 expression is reduced in cardiac pericytes in HFpEF and its loss reduces cellular adhesion and induces pericyte senescence
Leah Rebecca Vanicek, Ariane Fischer, Mariano Ruz Jurado, Anita Tamiato, Tara Procida‐Kowalski, Jochen Wilhelm, Dennis Hecker, Maximilian Merten, Felicitas Escher, Badder Kattih, Valentina Puntmann, David John, Marcel H. Schulz, Eike Nagel, Stefanie Dimmeler, Guillermo Luxán

TL;DR
Reduced STAT3 in cardiac pericytes contributes to heart failure with preserved ejection fraction by causing cell senescence and impaired adhesion.
Contribution
Identifies reduced STAT3 as a novel driver of pericyte dysfunction in HFpEF through in vitro and sequencing studies.
Findings
STAT3 expression is reduced in cardiac pericytes in HFpEF.
Loss of STAT3 induces pericyte senescence and impairs cellular adhesion.
STAT3 reduction activates a pro-fibrotic gene program in pericytes.
Abstract
Heart failure with preserved ejection fraction (HFpEF) accounts for half of heart failure cases and is characterised by reduced pericyte coverage. While the contributions of other cardiac cell types to HFpEF are well‐studied, the role of pericytes remains less understood. Using murine single‐nucleus RNA‐sequencing to study cardiac pericytes in HFpEF, we identified reduced STAT3 expression as a hallmark of HFpEF pericytes. Mechanistic studies in vitro revealed that STAT3 deletion induces cellular senescence and impairs pericyte adhesion, recapitulating HFpEF‐like characteristics. These findings suggest that STAT3 is crucial for maintaining pericyte homeostasis and highlight its reduction as a potential driver of pericyte loss, a defining feature of HFpEF. Heart failure with preserved ejection fraction (HFpEF) accounts for half of the heart failure cases. It is characterised by…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiac Fibrosis and Remodeling · Cardiovascular Function and Risk Factors · Cardiac Valve Diseases and Treatments
